Skip to content
Review Open access

Artificial intelligence for toxicokinetic parameterization in environmental exposure assessment

Sep 2026 · Journal of Environmental Exposure Assessment · 0 citations · 110 references

TL;DR

This review examines recent developments in AI-based TK parameterization with relevance to environmental exposure assessment and discusses current limitations and future perspectives, including model reliability, interpretability, data availability for environmental chemicals, and integrating AI-predicted TK parameters into mechanistic models.

Abstract

Toxicokinetics (TK) characterizes the absorption, distribution, metabolism, and excretion (ADME) of chemicals in the body and connects exposure with internal dose and potential toxicity. Because in vivo and in vitro TK assays are costly and low-throughput, and demand for emerging chemicals is growing, artificial intelligence and machine learning (AI/ML) offer alternative tools to predict ADME profiles for data-poor chemicals. This review examines recent developments in AI-based TK parameterization with relevance to environmental exposure assessment. First, we outline the essential elements of AI-based TK parameterization paradigms, including data sources, molecular representations, and commonly used ML algorithms. Second, the recent applications of AI/ML models across four ADME processes are introduced. Third, we discuss current limitations and future perspectives, including model reliability, interpretability, data availability for environmental chemicals, and integrating AI-predicted TK parameters into mechanistic models, such as physiologically based pharmacokinetic (PBPK) models and other downstream modeling frameworks. Although many existing studies rely on pharmaceutical or mixed chemical datasets, these approaches could support TK parameterization and exposure assessment for environmental chemicals. Further progress will depend on improved data quality, broader environmental chemical coverage, and more rigorous model validation and uncertainty evaluation.

Read PDF

Similar papers

#artificial intelligence Review Open access Sep 2026

Artificial intelligence for PFAS toxicology and risk assessment

The regulatory-readiness framework is expanded to incorporate OECD QSAR validation principles, chemical data curation, descriptor generation, applicability-domain assessment, scaffold-aware and prospective validation, explainability beyond SHAP, calibrated uncertainty analysis and AOP-linked mechanistic interpretation.

Abir Hamze, Emran Alotaibi · 0 citations
Review Open access Oct 2026

Artificial intelligence - driven toxicogenomics for predictive environmental and pharmaceutical safety

The significance of AI-based toxicogenomics in drug development, environmental contaminant screening, and regulatory toxicology, while addressing key challenges such as data heterogeneity, model interpretability, and regulatory acceptance is discussed.

Mohammed Monirul Islam, Sibghatullah Muhammad Ali Sangi, Girish Meravanige et al. · 0 citations
Review Open access Aug 2026

Artificial intelligence approaches for pollutant assessment and environmental toxicology

Predictive artificial intelligence applications in pollutant hazard assessment, environmental monitoring, exposure modeling, multi-omics integration, and regulatory decision support are examined.

Ehsan Ghassemi Barghi, F. Motafeghi, Jafar Gholami Gharab et al. · 0 citations
#graph neural networks Review Open access Oct 2026

A review on advances in chemical compound toxicology prediction

The accurate prediction of chemical toxicity remains a major challenge in drug development and chemical safety assessment because conventional approaches can be costly, time-consuming, ethically constrained, and limited in predictive performance. This review examines how artificial intelligence (AI), particularly machi...

Ahmed Hagag, Nada A. Elsayed, Ibrahim Abdelbaky · 0 citations
Open access Oct 2026

Integrating in silico ADME modeling with Tox21 toxicity profiling to support compound prioritization

Toxicity remains a leading cause of late-stage attrition in drug development and is heavily influenced by a compound’s ADME (Absorption, Distribution, Metabolism, and Excretion) properties. The ability of a molecule to reach its target tissue, persist in circulation, or undergo bioactivation fundamentally shapes its...

Pranav Shah, C. Weber, Nivedita Kinatukara et al. · 0 citations
Review Open access Sep 2026

[Metabolic Activations and Pharmacokinetics of Drugs Using Data-driven Modeling].

Pharmacological and toxicological assessments of a wide array of chemicals typically involve estimating human clearance through allometric extrapolation of in vivo animal data, using empirical compartmental and physiologically based pharmacokinetic (PBPK) models. Parameters for pharmacokinetic absorption, distribution,...

H. Yamazaki · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.